Suven Life Sciences, a biopharmaceutical company, witnessed a rise in share price on Tuesday after securing three product patents. One product patent from Eurasia (020227), one product patent from Japan (5540099) and from Mexico (319429) corresponding to the New Chemical Entities (NCEs) for the treatment of disorders associated with Neurodegenerative diseases and these patents are valid through 2029.

Shares of the company are trading at Rs 217, up Rs 9.45, or 4.55% at the Bombay Stock Exchange (BSE) on Tuesday at 10:09 a.m.

The scrip has touched an intra-day high of Rs 219.50 and low of Rs 206.50. The total volume of shares traded at the BSE is 86,146.